Prot# VMALS-002-2: A Phase 2a, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety of Engensis in Participants with Amyotrophic Lateral Sclerosis

Project: Research project

Project Details

StatusActive
Effective start/end date4/29/21 → 4/29/24

Funding

  • Worldwide Clinical Trials, Inc. (Prot# VMALS-002-2)
  • ViroMed Co., Ltd. (Prot# VMALS-002-2)